Search Results

Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 g ethinyl estradiol

Authors: Sutterlin M.W.; Bussen S.S.; Rieger L.; Dietl J.; Steck T.

Source: European Journal of Obstetrics and Gynecology and Reproductive Biology, Volume 107, Number 1, 26 March 2003 , pp. 57-61(5)

Publisher: Elsevier

Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial

Authors: Kwiecien M.; Edelman A.; Nichols M.D.; Jensen J.T.

Source: Contraception, Volume 67, Number 1, January 2003 , pp. 9-13(5)

Publisher: Elsevier

Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism

Authors: Ludicke F.; Gaspard U.J.; Demeyer F.; Scheen A.; Lefebvre P.

Source: Contraception, Volume 66, Number 6, December 2002 , pp. 411-415(5)

Publisher: Elsevier

Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene-environment interaction

Authors: Bloemenkamp K.W.M.; de Maat M.P.M.; Dersjant-Roorda M.C.; Helmerhorst F.M.; Kluft C.

Source: Vascular Pharmacology, Volume 39, Number 3, August 2002 , pp. 131-136(6)

Publisher: Elsevier

The effect of extending the pill-free interval on follicular activity - triphasic norgestimate/35 g ethinyl estradiol versus monophasic levonorgestrel/20 g ethinyl estradiol

Authors: Creinin M.D.; Lippman J.S.; Eder S.E.; Godwin A.J.; Olson W.

Source: Contraception, Volume 66, Number 3, September 2002 , pp. 147-152(6)

Publisher: Elsevier

Using a low-dose contraceptive in women 35 years of age and over: 20 g estradiol/100 g levonorgestrel*

Authors: Carr B.R.; DelConte A.

Source: Contraception, Volume 65, Number 6, June 2002 , pp. 397-402(6)

Publisher: Elsevier

Attitudes and experiences with levonorgestrel 100 g/ethinyl estradiol 20 g among women during a 3-month trial

Authors: Wimberly Y.H.; Cotton S.; Wanchick A.M.; Succop P.A.; Rosenthal S.L.

Source: Contraception, Volume 65, Number 6, June 2002 , pp. 403-406(4)

Publisher: Elsevier

Contraceptives and cerebral thrombosis: a five-year national case-control study*

Authors: Lidegaard O.; Kreiner S.

Source: Contraception, Volume 65, Number 3, March 2002 , pp. 197-205(9)

Publisher: Elsevier

Effect of dienogest-containing oral contraceptives on lipid metabolism

Authors: Wiegratz I.; Lee J.H.; Kutschera E.; Bauer H.H.; von Hayn C.; Moore C.; Mellinger U.; Winkler U.H.; Gross W.; Kuhl H.

Source: Contraception, Volume 65, Number 3, March 2002 , pp. 223-229(7)

Publisher: Elsevier

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 g ethinyl estradiol and 100 g levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables

Authors: Endrikat J.; Klipping C.; Cronin M.; Gerlinger C.; Ruebig A.; Schmidt W.; Dusterberg B.

Source: Contraception, Volume 65, Number 3, March 2002 , pp. 215-221(7)

Publisher: Elsevier

Pharmacokinetic overview of Ortho Evra&unknown;/Evra&unknown;

Authors: Abrams L.S.; Skee D.; Natarajan J.; Wong F.A.

Source: Fertility and Sterility, Volume 77, Supplement 2, February 2002 , pp. 3-12(10)

Publisher: Elsevier

The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions

Authors: Takeyoshi M.; Yamasaki K.; Sawaki M.; Nakai M.; Noda S.; Takatsuki M.

Source: Toxicology Letters, Volume 126, Number 2, 25 January 2002 , pp. 91-98(8)

Publisher: Elsevier

A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 g ethinyl estradiol and 75 g gestodene and a 21-day regimen with 30 g ethinyl estradiol and 75 g gestodene on hemostatic variables, lipids, and carbohydrate metabolism

Authors: Endrikat J.; Klipping C.; Gerlinger C.; Ruebig A.; Schmidt W.; Holler T.; Dusterberg B.

Source: Contraception, Volume 64, Number 4, October 2001 , pp. 235-241(7)

Publisher: Elsevier

Dose finding in a low-dose 21-day combined oral contraceptive containing gestodene

Authors: Ludicke F.; Sullivan H.; Spona J.; Elstein M.

Source: Contraception, Volume 64, Number 4, October 2001 , pp. 243-248(6)

Publisher: Elsevier

Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion

Authors: Schleussner E.; Brueckner T.; Brautigam J.; Michels W.

Source: Gynecological Endocrinology, Volume 15, Number 4, 1 August 2001 , pp. 259-264(6)

Publisher: Informa Healthcare

Clinical trial of a monophasic estroprogestin oral formulation containing 20 g ethinyl estradiol and 75 g gestodene

Authors: Lello S.; Monterubbianesi M.; Guardianelli F.; Bianchi C.; Simonelli C.

Source: Gynecological Endocrinology, Volume 15, Number 4, 1 August 2001 , pp. 265-271(7)

Publisher: Informa Healthcare

Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 g ethinyl estradiol and 75 g gestodene

Authors: Endrikat J.; Cronin M.; Gerlinger C.; Ruebig A.; Schmidt W.; Dusterberg B.

Source: Contraception, Volume 64, Number 2, August 2001 , pp. 99-105(7)

Publisher: Elsevier

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 g ethinyl estradiol and 75 g gestodene and a 21-day regimen with 20 g ethinyl estradiol and 150 g desogestrel

Authors: Endrikat J.; Cronin M.; Gerlinger C.; Ruebig A.; Schmidt W.; Dusterberg B.

Source: Contraception, Volume 64, Number 3, September 2001 , pp. 201-207(7)

Publisher: Elsevier

Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives

Authors: De Leo V.; la Marca A.; Morgante G.; Lucani B.; Nami R.; Ciotta L.; Cianci A.; Petraglia F.

Source: Contraception, Volume 64, Number 3, September 2001 , pp. 145-148(4)

Publisher: Elsevier

Efficacy and safety of a transdermal contraceptive system¹

Authors: Smallwood G.H.; Meador M.L.; Lenihan J.P.; Shangold G.A.; Fisher A.C.; Creasy G.W.; ORTHO EVRA/EVRA 002 Study Group

Source: Obstetrics and Gynecology, Volume 98, Number 5, November 2001 , pp. 799-805(7)

Publisher: Elsevier